WHO has been developing PQ technical specifications for IVDs to detect SARS-CoV-2 nucleic acid (closed systems and open platforms) and

The PQT In Vitro Diagnostics Assessment team held a two day consultation meeting  with experts in Geneva to review and finalize proposed performance study requirements for WHO prequalification

The PQT-IVD team held a joint assessment session from 5-9 June in Geneva session to pilot a new assessment model whereby assessors meet for a week during which they work in groups to assess product

The PQT Medicines 6th Annual Medicines Quality Workshop for Manufacturers will take place from 25 to 28 September 2023.